8-[8-[3-[2-fluoro-5-(trifluoromethyl)phenyl]-2-oxopropyl]quinolin-5-yl]oxy-4H-pyrido[2,3-b]pyrazin-3-one
C26H16F4N4O3 — CID 58171651
Data last refreshed: (MolForge compound catalog, from PubChem)
About 8-[8-[3-[2-fluoro-5-(trifluoromethyl)phenyl]-2-oxopropyl]quinolin-5-yl]oxy-4H-pyrido[2,3-b]pyrazin-3-one
8-[8-[3-[2-fluoro-5-(trifluoromethyl)phenyl]-2-oxopropyl]quinolin-5-yl]oxy-4H-pyrido[2,3-b]pyrazin-3-one (PubChem CID 58171651) has the molecular formula C26H16F4N4O3 and a molecular weight of 508.43 g/mol. Its IUPAC name is 8-[8-[3-[2-fluoro-5-(trifluoromethyl)phenyl]-2-oxopropyl]quinolin-5-yl]oxy-4H-pyrido[2,3-b]pyrazin-3-one.
Molecular Properties
| Compound Name | 8-[8-[3-[2-fluoro-5-(trifluoromethyl)phenyl]-2-oxopropyl]quinolin-5-yl]oxy-4H-pyrido[2,3-b]pyrazin-3-one |
|---|---|
| PubChem CID | 58171651 |
| Molecular Formula | C26H16F4N4O3 |
| Molecular Weight | 508.43 g/mol |
| Exact Mass | 508.12 |
| IUPAC Name | 8-[8-[3-[2-fluoro-5-(trifluoromethyl)phenyl]-2-oxopropyl]quinolin-5-yl]oxy-4H-pyrido[2,3-b]pyrazin-3-one |
| SMILES | O=C(Cc1cc(C(F)(F)F)ccc1F)Cc1ccc(Oc2ccnc3[nH]c(=O)cnc23)c2cccnc12 |
| InChI | InChI=1S/C26H16F4N4O3/c27-19-5-4-16(26(28,29)30)10-15(19)12-17(35)11-14-3-6-20(18-2-1-8-31-23(14)18)37-21-7-9-32-25-24(21)33-13-22(36)34-25/h1-10,13H,11-12H2,(H,32,34,36) |
| InChIKey | JCNJFZJZNGCEDD-UHFFFAOYSA-N |
| XLogP | 5.17 |
| TPSA | 97.83 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 37 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 508.43 |
| LogP ≤ 5 | 5.17 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 58171651 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.